Source:http://linkedlifedata.com/resource/umls/id/C0086130
CSP: N,alpha-dimethyl-N,2- propynyl phenethylamine, a MAO inhibitor which blocks the conversion of MPTP to MPP+ in animal models of Parkinson's disease, and may therefore have therapeutic potential.